Evidence map›Paper›PMID 19576856›Full record

ArticleClinical immunology (Orlando, Fla.)2009

Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design.

Larisa Ivanova, Iva Christova, Vera Neves, Miguel Aroso, Luciana Meirelles, Dustin Brisson, Maria Gomes-Solecki

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Concurrent Infection of the Human Brain with MultipleInternational journal of molecular sciences · 2023
    Article
  3. Review
  4. Article
  5. Evolution of theMicrobiology spectrum · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Pathogens (Basel, Switzerland) · 2021
    Article
  10. Laboratory Diagnosis of Lyme Borreliosis.Clinical microbiology reviews · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The role of Borrelia burgdorferi outer surface proteins.FEMS immunology and medical microbiology · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Larisa IvanovaDepartment of Molecular Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Iva Christova
Vera Neves
Miguel Aroso
Luciana Meirelles
Dustin Brisson
Maria Gomes-Solecki
Biopeptide (United States) · USUniversity of Tennessee Health Science Center · USUniversity of Pennsylvania · US

Funding

BAIT VACCINE AGAINST LYME BORRELIOSISR43AI072810 · NIAID · BIOPEPTIDES, INC. · PI GOMES-SOLECKI, MARIA · 2007 to 2008
$600k
Multi-peptide assay for serodiagnosis of Lyme diseaseR43AI074092 · NIAID · BIOPEPTIDES, INC. · PI GOMES-SOLECKI, MARIA · 2007 to 2008
$599k
NCEZID CDC HHS CK000107NCEZID CDC HHS U01 CK000107NIAID NIH HHS R43 AI072810NIAID NIH HHS R43AI072810NIAID NIH HHS R43 AI074092NIAID NIH HHS R43AI074092
6 · The paper itself

Abstract

Early diagnosis of Lyme disease (LD) is critical to successful treatment. However, current serodiagnostic tests do not reliably detect antibodies during early infection. OspC induces a potent early immune response and is also one of the most diverse proteins in the Borrelia proteome. Yet, at least 70% of the amino acid sequence is conserved among all 21 known OspC types. We performed a series of comprehensive seroprofiling studies to select the OspC types that have the most cross-reactive immunodominant epitopes. We found that proteins belonging to seven OspC types detect antibodies from all three infected host species regardless of the OspC genotype of the infecting strain. Although no one OspC type identifies all seropositive human samples, combinations of as few as two OspC proteins identified all patients that had anti-OspC antibodies.

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsAnimalsCross ReactionsDogsGenotypeHumansImmunodominant EpitopesImmunoglobulin GImmunoglobulin MLyme DiseaseMaleMiceMice, Inbred C3HPeromyscusRecombinant ProteinsAntigens, BacterialBacterial Outer Membrane ProteinsImmunodominant EpitopesImmunoglobulin GImmunoglobulin MOspC proteinRecombinant Proteins

Identifiers

PMID19576856
PMCPMC2752154
OpenAlexW2012244764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.